Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W Weder

Showing results (191-200 of 201) with videos related to

Pageof 21
Sort By:
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 13, 2007
Multicenter trial of neo-adjuvant chemotherapy followed by extrapleural pneumonectomy in malignant pleural mesotheliomaW Weder, R A Stahel, J Bernhard, et al.
The European Respiratory Journal|March 3, 2007
Densitometry for assessment of effect of lung volume reduction surgery for emphysemaJ Stolk, M I M Versteegh, L J Montenij, et al.
Zhongguo Fei AI Za Zhi = Chinese Journal of Lung Cancer|October 28, 2010
[Guidelines of the European Respiratory Society and the European Society of Thoracic Surgeons for the management of malignant pleural mesothelioma]A Scherpereel, P Astoul, P Baas, et al.
The European Respiratory Journal|September 1, 2009
Guidelines of the European Respiratory Society and the European Society of Thoracic Surgeons for the management of malignant pleural mesotheliomaA Scherpereel, P Astoul, P Baas, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 25, 2020
Local delivery of CAR T cells targeting fibroblast activation protein is safe in patients with pleural mesothelioma: first report of FAPME, a phase I clinical trialS Hiltbrunner, C Britschgi, P Schuberth, et al.
British Journal of Cancer|April 20, 2006
Prognostic factors affecting long-term outcomes in patients with resected stage IIIA pN2 non-small-cell lung cancer: 5-year follow-up of a phase II studyD C Betticher, S-F Hsu Schmitz, M Tötsch, et al.
ESMO Open|April 25, 2022
Corrigendum to 'Long-term outcomes of operable stage III NSCLC in the pre-immunotherapy era: results from a pooled analysis of the SAKK 16/96, SAKK 16/00, SAKK 16/01, and SAKK 16/08 trials': [ESMO Open Volume 7, Issue 2, (2022), 100455]D König, S Schär, D Vuong, et al.
ESMO Open|April 10, 2022
Long-term outcomes of operable stage III NSCLC in the pre-immunotherapy era: results from a pooled analysis of the SAKK 16/96, SAKK 16/00, SAKK 16/01, and SAKK 16/08 trialsD König, S Schär, D Vuong, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 30, 2017
Prevalence and clinical association of gene mutations through multiplex mutation testing in patients with NSCLC: results from the ETOP Lungscape ProjectK M Kerr, U Dafni, K Schulze, et al.
European Journal of Cardio-Thoracic Surgery : Official Journal of the European Association for Cardio-Thoracic Surgery|September 28, 2001
Structure of general thoracic surgery in EuropeW Klepetko, T H Aberg, A E Lerut, et al.
Pageof 21

Showing results (191-200 of 201) with videos related to

Sort By:
Pageof 21
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 13, 2007
Multicenter trial of neo-adjuvant chemotherapy followed by extrapleural pneumonectomy in malignant pleural mesotheliomaW Weder, R A Stahel, J Bernhard, et al.
The European Respiratory Journal|March 3, 2007
Densitometry for assessment of effect of lung volume reduction surgery for emphysemaJ Stolk, M I M Versteegh, L J Montenij, et al.
Zhongguo Fei AI Za Zhi = Chinese Journal of Lung Cancer|October 28, 2010
[Guidelines of the European Respiratory Society and the European Society of Thoracic Surgeons for the management of malignant pleural mesothelioma]A Scherpereel, P Astoul, P Baas, et al.
The European Respiratory Journal|September 1, 2009
Guidelines of the European Respiratory Society and the European Society of Thoracic Surgeons for the management of malignant pleural mesotheliomaA Scherpereel, P Astoul, P Baas, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 25, 2020
Local delivery of CAR T cells targeting fibroblast activation protein is safe in patients with pleural mesothelioma: first report of FAPME, a phase I clinical trialS Hiltbrunner, C Britschgi, P Schuberth, et al.
British Journal of Cancer|April 20, 2006
Prognostic factors affecting long-term outcomes in patients with resected stage IIIA pN2 non-small-cell lung cancer: 5-year follow-up of a phase II studyD C Betticher, S-F Hsu Schmitz, M Tötsch, et al.
ESMO Open|April 25, 2022
Corrigendum to 'Long-term outcomes of operable stage III NSCLC in the pre-immunotherapy era: results from a pooled analysis of the SAKK 16/96, SAKK 16/00, SAKK 16/01, and SAKK 16/08 trials': [ESMO Open Volume 7, Issue 2, (2022), 100455]D König, S Schär, D Vuong, et al.
ESMO Open|April 10, 2022
Long-term outcomes of operable stage III NSCLC in the pre-immunotherapy era: results from a pooled analysis of the SAKK 16/96, SAKK 16/00, SAKK 16/01, and SAKK 16/08 trialsD König, S Schär, D Vuong, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 30, 2017
Prevalence and clinical association of gene mutations through multiplex mutation testing in patients with NSCLC: results from the ETOP Lungscape ProjectK M Kerr, U Dafni, K Schulze, et al.
European Journal of Cardio-Thoracic Surgery : Official Journal of the European Association for Cardio-Thoracic Surgery|September 28, 2001
Structure of general thoracic surgery in EuropeW Klepetko, T H Aberg, A E Lerut, et al.
Pageof 21